iShares U.S. Pharmaceuticals ETF Rating $68.39 +0.33 (+0.48%) (As of 11/22/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.62Holdings in IHE have an aggregate rating of Moderate Buy based on 314 analyst ratings issued in the past year covering 38 companies (99.8% of the portfolio).IHE Aggregate Price Target$68.39High Prediction$68.39Average Prediction$68.39Low Prediction$68.39Holdings in IHE have an aggregate price target of $68.39 and a range of $68.39 to $68.39 covering 38 companies (99.8% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings22.06%JNJJohnson & Johnson$155.14-0.2%4.9567 of 5 stars2.53$175.94 13.4%15Positive News18.83%LLYEli Lilly and Company$748.01-0.3%4.9919 of 5 stars2.81$1,007.94 34.8%21Analyst Revision5.70%BMYBristol-Myers Squibb$58.87+1.1%4.7982 of 5 stars2.20$54.07 -8.2%20Analyst RevisionPositive News5.47%VTRSViatris$13.37+1.8%1.4394 of 5 stars2.00$13.33 -0.3%3News Coverage4.41%CTLTCatalent$60.98+2.2%3.0832 of 5 stars2.00$63.40 4.0%7Analyst DowngradeHigh Trading Volume4.39%ZTSZoetis$176.98+0.2%4.8738 of 5 stars3.10$221.44 25.1%10Positive News4.17%RPRXRoyalty Pharma$26.43+0.1%4.782 of 5 stars2.83$41.67 57.6%64.02%PFEPfizer$25.63+2.0%5 of 5 stars2.50$32.92 28.5%16Analyst DowngradeOptions VolumeAnalyst Revision4.00%MRKMerck & Co., Inc.$99.17-0.7%4.9978 of 5 stars2.68$130.86 32.0%19Dividend IncreasePositive News3.39%ITCIIntra-Cellular Therapies$85.69+0.3%4.4537 of 5 stars2.85$97.23 13.5%13Positive News2.98%JAZZJazz Pharmaceuticals$126.67+1.3%4.8871 of 5 stars2.80$175.33 38.4%15Analyst ForecastNews CoverageGap Up2.72%ELANElanco Animal Health$13.35-0.4%3.8657 of 5 stars2.43$17.14 28.4%72.09%CORTCorcept Therapeutics$57.54+2.9%4.7596 of 5 stars3.00$65.25 13.4%5Analyst RevisionPositive News1.69%PBHPrestige Consumer Healthcare$84.85+0.8%3.8008 of 5 stars2.67$83.67 -1.4%3Insider Trade1.59%AXSMAxsome Therapeutics$98.68+0.5%4.6105 of 5 stars3.00$124.93 26.6%14Analyst Upgrade1.55%OGNOrganon & Co.$15.28+2.6%4.7485 of 5 stars2.50$21.33 39.6%41.54%PRGOPerrigo$28.07+3.7%4.9831 of 5 stars2.75$37.00 31.8%4Positive News0.84%LGNDLigand Pharmaceuticals$119.19+2.3%4.9274 of 5 stars3.00$144.83 21.5%6Positive News0.81%SUPNSupernus Pharmaceuticals$36.22+1.1%2.5242 of 5 stars2.50$36.00 -0.6%20.76%EWTXEdgewise Therapeutics$32.20+0.7%2.7014 of 5 stars3.00$39.50 22.7%6Analyst ForecastNews CoverageGap Up0.69%AMPHAmphastar Pharmaceuticals$45.46+2.0%4.8709 of 5 stars2.50$60.33 32.7%4Analyst ForecastPositive NewsGap Up0.67%TARSTarsus Pharmaceuticals$48.24+4.0%1.9244 of 5 stars3.00$54.20 12.4%70.57%ARVNArvinas$25.86+3.0%3.067 of 5 stars2.93$61.08 136.2%14Analyst ForecastAnalyst RevisionNews CoverageGap Up0.52%AMRXAmneal Pharmaceuticals$8.39+0.8%3.2183 of 5 stars2.80$10.00 19.2%5Insider TradeNews Coverage0.52%SAVACassava Sciences$26.48-17.7%3.7573 of 5 stars3.00$111.50 321.1%2Gap DownHigh Trading Volume0.51%HRMYHarmony Biosciences$34.07+2.5%4.8459 of 5 stars2.56$47.00 38.0%90.43%INVAInnoviva$19.15+0.5%1.3032 of 5 stars3.001News Coverage0.40%COLLCollegium Pharmaceutical$29.96-1.5%4.064 of 5 stars2.60$42.60 42.2%5Positive News0.38%ANIPANI Pharmaceuticals$56.91+1.9%4.2898 of 5 stars2.83$77.33 35.9%6Positive News0.34%NMRANeumora Therapeutics$9.74+0.5%1.4224 of 5 stars2.71$21.67 122.5%7Analyst Forecast0.32%PCRXPacira BioSciences$17.55+1.0%4.0044 of 5 stars2.20$23.50 33.9%10Positive News0.32%ELVNEnliven Therapeutics$24.54-3.4%2.394 of 5 stars3.25$37.00 50.8%40.28%PLRXPliant Therapeutics$12.98+1.0%3.4996 of 5 stars3.11$40.57 212.6%90.22%MNMDMind Medicine (MindMed)$7.56+6.6%2.4454 of 5 stars3.25$25.38 235.6%12Analyst Revision0.18%NUVBNuvation Bio$2.81+3.7%2.3507 of 5 stars3.00$6.60 135.3%5High Trading Volume0.14%TBPHTheravance Biopharma$9.47-1.5%1.4021 of 5 stars2.40$13.75 45.2%50.14%RVNCRevance Therapeutics$3.73-2.9%3.9855 of 5 stars2.11$9.66 158.9%90.14%PHATPhathom Pharmaceuticals$9.34-1.2%2.628 of 5 stars2.75$22.50 140.9%4 This page (NYSEARCA:IHE) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IHE Stock Alerts